NASDAQ: $AMGN A Significant Update for Small Cell Lung Cancer Treatment The landscape for treating extensive-stage small cell lung cancer (ES-SCLC) is evolving. The FDA has recently approved a label update for Imdelltra (tarlatamab-dlle), specifically changing the requirements for patient monitoring after the administration of the first two doses. What Has Changed? Previously, patients receiving…